Acute Kidney Injury in Adult Patients Receiving Extracorporeal Membrane Oxygenation: A Systematic Review
DOI:
https://doi.org/10.61882/rjccn.2.01.31Keywords:
extracorporeal membrane oxygenation, ECMO, acute kidney injury, renal replacement therapy, CRRT, mortalityAbstract
Introduction. Acute kidney injury (AKI) is a frequent and
clinically important complication in adults receiving extracorporeal
membrane oxygenation (ECMO), yet reported incidence and
associated outcomes vary widely due to differences in populations,
ECMO configuration, and AKI definitions. We systematically
reviewed full-text studies reporting AKI and related outcomes in
adult patients supported with veno-arterial (VA) and/or veno
venous (VV) ECMO.
Methods. A systematic search of PubMed identified 661 records;
660 remained after deduplication. Full texts available for assessment
were screened for eligibility (n = 126). We included original adult
ECMO/ECLS studies reporting extractable AKI and/or renal
replacement therapy (RRT/CRRT) outcomes.
Results. Forty-five studies were included in qualitative synthesis.
AKI incidence was extractable in 29 studies and ranged from
2.3% to 89.0% (median 50.5%). RRT/CRRT use was extractable
in 29 studies and ranged from 1.8% to 91.0% (median 53.3%).
Mortality was extractable in 37 studies (ICU, in-hospital, or 30
day) and ranged from 6.0% to 95.0% (median 53.3%). KDIGO
was the most frequently referenced AKI definition (reported in
26 studies), followed by RIFLE (19) and AKIN (11), with overlap
across studies.
Conclusions. AKI and RRT/CRRT use are common in adults
receiving ECMO, with substantial variability driven by clinical
heterogeneity and inconsistent AKI definitions and outcome
reporting. Standardized AKI definitions and harmonized
reporting of renal and mortality outcomes are needed to improve
comparability and guide future ECMO–kidney research.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Research Journal of Critical Care Nephrology

This work is licensed under a Creative Commons Attribution 4.0 International License.